Tchernev Georgi, Patterson James W, Bakardzhiev Ilko, Lotti Torello, Lotti Jacopo, França Katlein, Batashki Atanas, Wollina Uwe
Department of Dermatology, Venereology and Dermatologic Surgery, Medical Institute of Ministry of Interior, and Onkoderma Polyclinic for Dermatology and Dermatologic Surgery, Sofia, Bulgaria.
Departments of Pathology and Dermatology, University of Virginia Health System, Hospital Expansion, 3rd Floor, 1215 Lee Street, Charlottesville, VA, USA.
Open Access Maced J Med Sci. 2017 Jul 18;5(4):533-534. doi: 10.3889/oamjms.2017.077. eCollection 2017 Jul 25.
A 61-year-old woman, with a lifelong history of a giant congenital melanocytic nevus in the occipital region with secondary development of giant melanoma is presented. Surgical excision was performed, and the histopathological evaluation confirmed the diagnosis of Giant Malignant Melanoma (GMM) with a maximum tumour thickness of 16 mm. Nowadays, there is tremendous uncertainty regarding how giant congenital melanocytic nevi (GCMN) should be treated. The standard approach to patients with late onset giant congenital melanocytic nevi (GCMN is based on two main considerations: (1) obtain an acceptable cosmetic results with the purpose to decrease the psychosocial inconvenience to each patient, and (2) to attempt to minimise the risk of development of malignant transformation. Unfortunately complete surgical removal of the GCMN is usually difficult and very often impossible without subsequent functional or cosmetic mutilations.
本文介绍了一位61岁女性,其枕部有巨大先天性黑素细胞痣的终生病史,并继发巨大黑色素瘤。进行了手术切除,组织病理学评估证实为巨大恶性黑色素瘤(GMM),最大肿瘤厚度为16mm。目前,对于如何治疗巨大先天性黑素细胞痣(GCMN)存在极大的不确定性。对于晚发性巨大先天性黑素细胞痣(GCMN)患者的标准治疗方法基于两个主要考虑因素:(1)获得可接受的美容效果,以减少对每位患者的心理社会不便,(2)试图将恶变风险降至最低。不幸的是,完全手术切除GCMN通常很困难,而且如果不造成后续功能或美容损伤,往往是不可能的。